Literature DB >> 34209990

Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis.

Soraya Mousavi1, Dennis Weschka1, Stefan Bereswill1, Markus M Heimesaat1.   

Abstract

Human campylobacteriosis, commonly caused by Campylobacter jejuni, is a food-borne infection with rising prevalence causing significant health and socioeconomic burdens worldwide. Given the threat from emerging antimicrobial resistances, the treatment of infectious diseases with antibiotics-independent natural compounds is utmost appreciated. Since the health-beneficial effects of cumin-essential-oil (EO) have been known for centuries, its potential anti-pathogenic and immune-modulatory effects during acute experimental campylobacteriosis were addressed in the present study. Therefore, C. jejuni-challenged secondary abiotic IL-10-/- mice were treated perorally with either cumin-EO or placebo starting on day 2 post-infection. On day 6 post-infection, cumin-EO treated mice harbored lower ileal pathogen numbers and exhibited a better clinical outcome when compared to placebo controls. Furthermore, cumin-EO treatment alleviated enteropathogen-induced apoptotic cell responses in colonic epithelia. Whereas, on day 6 post-infection, a dampened secretion of pro-inflammatory mediators, including nitric oxide and IFN-γ to basal levels, could be assessed in mesenteric lymph nodes of cumin-EO treated mice, systemic MCP-1 concentrations were elevated in placebo counterparts only. In conclusion, our preclinical intervention study provides first evidence for promising immune-modulatory effects of cumin-EO in the combat of human campylobacteriosis. Future studies should address antimicrobial and immune-modulatory effects of natural compounds as adjunct antibiotics-independent treatment option for infectious diseases.

Entities:  

Keywords:  Campylobacter jejuni; cumin-essential-oil; cuminaldehyde; enteropathogenic infection; experimental campylobacteriosis model; host–pathogen interaction; immune-modulatory effects; natural antibiotics-independent compounds; preclinical intervention study; secondary abiotic IL-10-/- mice

Year:  2021        PMID: 34209990     DOI: 10.3390/pathogens10070818

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  44 in total

Review 1.  Campylobacter infections in human beings.

Authors:  P J Rettig
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

Review 2.  The second century of Campylobacter research: recent advances, new opportunities and old problems.

Authors:  Nick Dorrell; Brendan W Wren
Journal:  Curr Opin Infect Dis       Date:  2007-10       Impact factor: 4.915

3.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

Review 4.  Cumin (Cuminum cyminum L.) is a safe approach for management of lipid parameters: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Amir Hadi; Hamed Mohammadi; Zohreh Hadi; Neda Roshanravan; Marzieh Kafeshani
Journal:  Phytother Res       Date:  2018-08-08       Impact factor: 5.878

5.  Cuminum cyminum and Carum carvi: An update.

Authors:  R K Johri
Journal:  Pharmacogn Rev       Date:  2011-01

6.  Antibiotic resistance modulation and modes of action of (-)-α-pinene in Campylobacter jejuni.

Authors:  Jasna Kovač; Katarina Šimunović; Zuowei Wu; Anja Klančnik; Franz Bucar; Qijing Zhang; Sonja Smole Možina
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

7.  Vitamin D in Acute Campylobacteriosis-Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model.

Authors:  Soraya Mousavi; Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker; Stefan Bereswill; Markus M Heimesaat
Journal:  Front Immunol       Date:  2019-09-03       Impact factor: 7.561

8.  Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study.

Authors:  Markus M Heimesaat; Soraya Mousavi; Ulrike Escher; Fábia Daniela Lobo de Sá; Elisa Peh; Jörg-Dieter Schulzke; Sophie Kittler; Roland Bücker; Stefan Bereswill
Journal:  Microorganisms       Date:  2020-11-25

9.  Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis.

Authors:  Markus M Heimesaat; Soraya Mousavi; Dennis Weschka; Stefan Bereswill
Journal:  Microorganisms       Date:  2021-01-14

Review 10.  Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Microorganisms       Date:  2020-03-28
View more
  1 in total

Review 1.  Nanomedicine as an Emerging Technology to Foster Application of Essential Oils to Fight Cancer.

Authors:  Khaled AbouAitah; Witold Lojkowski
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.